These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 31662153)

  • 21. Ex vivo gene therapy for the treatment of neurological disorders.
    Gowing G; Svendsen S; Svendsen CN
    Prog Brain Res; 2017; 230():99-132. PubMed ID: 28552237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regenerative cellular therapies for neurologic diseases.
    Levy M; Boulis N; Rao M; Svendsen CN
    Brain Res; 2016 May; 1638(Pt A):88-96. PubMed ID: 26239912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell therapy for central nervous system disorders: Current obstacles to progress.
    Yasuhara T; Kawauchi S; Kin K; Morimoto J; Kameda M; Sasaki T; Bonsack B; Kingsbury C; Tajiri N; Borlongan CV; Date I
    CNS Neurosci Ther; 2020 Jun; 26(6):595-602. PubMed ID: 31622035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biotherapies in stroke.
    Detante O; Jaillard A; Moisan A; Barbieux M; Favre IM; Garambois K; Hommel M; Remy C
    Rev Neurol (Paris); 2014 Dec; 170(12):779-98. PubMed ID: 25459115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stem Cell Sources and Their Potential for the Treatment of Retinal Degenerations.
    Canto-Soler V; Flores-Bellver M; Vergara MN
    Invest Ophthalmol Vis Sci; 2016 Apr; 57(5):ORSFd1-9. PubMed ID: 27116661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transplantation of Human Chorion-Derived Cholinergic Progenitor Cells: a Novel Treatment for Neurological Disorders.
    Mohammadi A; Maleki-Jamshid A; Sanooghi D; Milan PB; Rahmani A; Sefat F; Shahpasand K; Soleimani M; Bakhtiari M; Belali R; Faghihi F; Joghataei MT; Perry G; Mozafari M
    Mol Neurobiol; 2019 Jan; 56(1):307-318. PubMed ID: 29549645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stem cells for the treatment of neurological disorders.
    Lindvall O; Kokaia Z
    Nature; 2006 Jun; 441(7097):1094-6. PubMed ID: 16810245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neural Stem Cells and Human Induced Pluripotent Stem Cells to Model Rare CNS Diseases.
    De Filippis L; Zalfa C; Ferrari D
    CNS Neurol Disord Drug Targets; 2017; 16(8):915-926. PubMed ID: 28641519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stem Cells for Retinal Disease: A Perspective on the Promise and Perils.
    Rao RC; Dedania VS; Johnson MW
    Am J Ophthalmol; 2017 Jul; 179():32-38. PubMed ID: 28428049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis.
    Uccelli A; Laroni A; Brundin L; Clanet M; Fernandez O; Nabavi SM; Muraro PA; Oliveri RS; Radue EW; Sellner J; Soelberg Sorensen P; Sormani MP; Wuerfel JT; Battaglia MA; Freedman MS;
    Trials; 2019 May; 20(1):263. PubMed ID: 31072380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Stem cell-based treatment of neurologic diseases].
    Costa C; Comabella M; Montalban X
    Med Clin (Barc); 2012 Jul; 139(5):208-14. PubMed ID: 22361347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stem cell therapy for neurologic disorders: therapeutic potential of adipose-derived stem cells.
    Safford KM; Rice HE
    Curr Drug Targets; 2005 Feb; 6(1):57-62. PubMed ID: 15720213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Economic Evaluation of Stem Cell Therapies in Neurological Diseases: A Systematic Review.
    Nagpal A; Milte R; Kim SW; Hillier S; Hamilton-Bruce MA; Ratcliffe J; Koblar SA
    Value Health; 2019 Feb; 22(2):254-262. PubMed ID: 30711072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetically engineered human neural stem cells for brain repair in neurological diseases.
    Kim SU
    Brain Dev; 2007 May; 29(4):193-201. PubMed ID: 17303360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glia: an emerging target for neurological disease therapy.
    Almad AA; Maragakis NJ
    Stem Cell Res Ther; 2012 Sep; 3(5):37. PubMed ID: 23021042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [New and future treatments for neurological disorders--knowledge essential to daily clinics and future prospects. Topics: 15. Therapeutic application of iPS cells].
    Kondo T; Inoue H; Takahashi R
    Nihon Naika Gakkai Zasshi; 2013 Aug; 102(8):2015-22. PubMed ID: 24167862
    [No Abstract]   [Full Text] [Related]  

  • 37. Role of endogenous neural stem cells in neurological disease and brain repair.
    Dietrich J; Kempermann G
    Adv Exp Med Biol; 2006; 557():191-220. PubMed ID: 16955712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances in stem cell therapy.
    Pérez López S; Otero Hernández J
    Adv Exp Med Biol; 2012; 741():290-313. PubMed ID: 22457117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current and future applications for stem cell therapies in spine surgery.
    Goldschlager T; Oehme D; Ghosh P; Zannettino A; Rosenfeld JV; Jenkin G
    Curr Stem Cell Res Ther; 2013 Sep; 8(5):381-93. PubMed ID: 23971834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induced pluripotent stem cells for the treatment of stroke: the potential and the pitfalls.
    Yu F; Li Y; Morshead CM
    Curr Stem Cell Res Ther; 2013 Sep; 8(5):407-14. PubMed ID: 23895059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.